INCERIFY Trademark

Trademark Overview


On Monday, May 6, 2024, a trademark application was filed for INCERIFY with the United States Patent and Trademark Office. The USPTO has given the INCERIFY trademark a serial number of 98534840. The federal status of this trademark filing is SUSPENSION LETTER - MAILED as of Monday, August 12, 2024. This trademark is owned by AstraZeneca AB. The INCERIFY trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for use in oncology
incerify

General Information


Serial Number98534840
Word MarkINCERIFY
Filing DateMonday, May 6, 2024
Status653 - SUSPENSION LETTER - MAILED
Status DateMonday, August 12, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesPharmaceutical preparations and substances for use in oncology

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, May 6, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAstraZeneca AB
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressSodertalje SE-15185
SE

Trademark Events


Event DateEvent Description
Monday, May 6, 2024NEW APPLICATION ENTERED
Monday, August 5, 2024ASSIGNED TO EXAMINER
Monday, August 12, 2024NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, August 12, 2024LETTER OF SUSPENSION E-MAILED
Monday, August 12, 2024SUSPENSION LETTER WRITTEN
Thursday, October 31, 2024TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Monday, May 6, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED